Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 202

1.

Validity of a long-term cardiovascular disease risk prediction equation for low-incidence populations: The CAMUNI-MATISS Cohorts Collaboration Study.

Veronesi G, Gianfagna F, Giampaoli S, Chambless LE, Grassi G, Cesana G, Ferrario MM.

Eur J Prev Cardiol. 2014 Dec 11. pii: 2047487314563709. [Epub ahead of print]

PMID:
25501263
2.

Reproducibility of Left Ventricular Mass by Echocardiogram in the ELSA-Brasil.

Tognon AP, Foppa M, Luft VC, Chambless LE, Lotufo P, El Aouar LM, Fernandes LP, Duncan BB.

Arq Bras Cardiol. 2015 Feb;104(2):104-11. doi: 10.5935/abc.20140183. Epub 2014 Nov 28. English, Portuguese.

3.

Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study.

Gianfagna F, Veronesi G, Guasti L, Chambless LE, Brambilla P, Corrao G, Mancia G, Cesana G, Ferrario MM.

Atherosclerosis. 2014 Sep;236(1):175-81. doi: 10.1016/j.atherosclerosis.2014.06.029. Epub 2014 Jul 14.

PMID:
25062081
4.

The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions: The MORGAM Project Cohort Component.

Ferrario MM, Veronesi G, Chambless LE, Tunstall-Pedoe H, Kuulasmaa K, Salomaa V, Borglykke A, Hart N, Söderberg S, Cesana G; MORGAM Project.

Heart. 2014 Aug;100(15):1179-87. doi: 10.1136/heartjnl-2013-304664. Epub 2014 May 1.

PMID:
24794139
5.

Improving long-term prediction of first cardiovascular event: the contribution of family history of coronary heart disease and social status.

Veronesi G, Gianfagna F, Giampaoli S, Chambless LE, Mancia G, Cesana G, Ferrario MM.

Prev Med. 2014 Jul;64:75-80. doi: 10.1016/j.ypmed.2014.04.007. Epub 2014 Apr 13.

PMID:
24732715
6.

Possible race and gender divergence in association of genetic variations with plasma von Willebrand factor: a study of ARIC and 1000 genome cohorts.

Zhou Z, Yu F, Buchanan A, Fu Y, Campos M, Wu KK, Chambless LE, Folsom AR, Boerwinkle E, Dong JF.

PLoS One. 2014 Jan 17;9(1):e84810. doi: 10.1371/journal.pone.0084810. eCollection 2014.

7.

Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study).

Chang PP, Chambless LE, Shahar E, Bertoni AG, Russell SD, Ni H, He M, Mosley TH, Wagenknecht LE, Samdarshi TE, Wruck LM, Rosamond WD.

Am J Cardiol. 2014 Feb 1;113(3):504-10. doi: 10.1016/j.amjcard.2013.10.032. Epub 2013 Nov 9.

8.

Long-term prediction of major coronary or ischaemic stroke event in a low-incidence Southern European population: model development and evaluation of clinical utility.

Veronesi G, Gianfagna F, Chambless LE, Giampaoli S, Mancia G, Cesana G, Ferrario MM.

BMJ Open. 2013 Nov 12;3(11):e003630. doi: 10.1136/bmjopen-2013-003630.

9.

Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.

Nambi V, Liu X, Chambless LE, de Lemos JA, Virani SS, Agarwal S, Boerwinkle E, Hoogeveen RC, Aguilar D, Astor BC, Srinivas PR, Deswal A, Mosley TH, Coresh J, Folsom AR, Heiss G, Ballantyne CM.

Clin Chem. 2013 Dec;59(12):1802-10. doi: 10.1373/clinchem.2013.203638. Epub 2013 Sep 13.

10.

Hyperglycemia and arterial stiffness: the Atherosclerosis Risk in the Communities study.

Rubin J, Nambi V, Chambless LE, Steffes MW, Juraschek SP, Coresh J, Sharrett AR, Selvin E.

Atherosclerosis. 2012 Nov;225(1):246-51. doi: 10.1016/j.atherosclerosis.2012.09.003. Epub 2012 Sep 13.

11.

The effect of revascularization procedures on myocardial infarction incidence rates and time trends: the MONICA-Brianza and CAMUNI MI registries in Northern Italy.

Veronesi G, Ferrario MM, Chambless LE, Borsani A, Fornari C, Cesana G.

Ann Epidemiol. 2012 Aug;22(8):547-53. doi: 10.1016/j.annepidem.2012.04.022. Epub 2012 Jun 12.

PMID:
22695389
12.

Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study.

Agarwal SK, Chambless LE, Ballantyne CM, Astor B, Bertoni AG, Chang PP, Folsom AR, He M, Hoogeveen RC, Ni H, Quibrera PM, Rosamond WD, Russell SD, Shahar E, Heiss G.

Circ Heart Fail. 2012 Jul 1;5(4):422-9. doi: 10.1161/CIRCHEARTFAILURE.111.964841. Epub 2012 May 15.

13.

Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008.

Rosamond WD, Chambless LE, Heiss G, Mosley TH, Coresh J, Whitsel E, Wagenknecht L, Ni H, Folsom AR.

Circulation. 2012 Apr 17;125(15):1848-57. doi: 10.1161/CIRCULATIONAHA.111.047480. Epub 2012 Mar 15.

14.

Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study.

Agarwal SK, Heiss G, Barr RG, Chang PP, Loehr LR, Chambless LE, Shahar E, Kitzman DW, Rosamond WD.

Eur J Heart Fail. 2012 Apr;14(4):414-22. doi: 10.1093/eurjhf/hfs016. Epub 2012 Feb 25.

15.

Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria.

Rosamond WD, Chang PP, Baggett C, Johnson A, Bertoni AG, Shahar E, Deswal A, Heiss G, Chambless LE.

Circ Heart Fail. 2012 Mar 1;5(2):152-9. doi: 10.1161/CIRCHEARTFAILURE.111.963199. Epub 2012 Jan 23.

16.

Effect of correcting for long-term variation in major coronary heart disease risk factors: relative hazard estimation and risk prediction in the Atherosclerosis Risk in Communities Study.

Paynter NP, Crainiceanu CM, Sharrett AR, Chambless LE, Coresh J.

Ann Epidemiol. 2012 Mar;22(3):191-7. doi: 10.1016/j.annepidem.2011.12.001. Epub 2012 Jan 4.

17.

Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.

Campos M, Buchanan A, Yu F, Barbalic M, Xiao Y, Chambless LE, Wu KK, Folsom AR, Boerwinkle E, Dong JF.

Blood. 2012 Feb 23;119(8):1929-34. doi: 10.1182/blood-2011-10-383661. Epub 2012 Jan 4.

18.

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.

Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM.

Circulation. 2011 Apr 5;123(13):1367-76. doi: 10.1161/CIRCULATIONAHA.110.005264. Epub 2011 Mar 21.

19.

Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort.

Campos M, Sun W, Yu F, Barbalic M, Tang W, Chambless LE, Wu KK, Ballantyne C, Folsom AR, Boerwinkle E, Dong JF.

Blood. 2011 May 12;117(19):5224-30. doi: 10.1182/blood-2010-08-300152. Epub 2011 Feb 22.

20.

Comparing measurement error correction methods for rate-of-change exposure variables in survival analysis.

Veronesi G, Ferrario MM, Chambless LE.

Stat Methods Med Res. 2013 Dec;22(6):583-97. doi: 10.1177/0962280210395742. Epub 2011 Feb 7.

PMID:
21300627
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk